The Milton and Carroll Petrie Department of Urology is part of the Mount Sinai Health System and has been a leader in clinical practice, research, and education since 1852, with the establishment of the Mount Sinai Hospital. Today, depth of knowledge, breadth of experience, and compassion for patients continue to characterize our highly respected team of board certified and fellowship trained physicians whom are also faculty of the Icahn School of Medicine at Mount Sinai. Our dedicated team of urologists specialize in treatment of urologic cancer, kidney stones, sexual dysfunction, and endourological conditions. Our surgeons and scientists have pioneered the adoption of novel diagnostic techniques and minimally invasive treatments for prostate, kidney, bladder, and renal cell cancers though our industry-leading international symposia.
As globally recognized experts, we provide in depth training on cutting-edge medical advances and are among the most renowned in the world performing robotic surgery making our robotics program among the most robust in the country. Our Kidney Stone Center was the first of its kind in New York, focusing on both treatment and prevention. Genomic testing and advanced imaging are routine for patients with prostate cancer in order to provide them with the most personalized and precise treatment protocols. Our specialized men’s, women’s, children’s, reconstructive and gender affirming programs ensure that we can meet the needs of every patient with exceptional quality of service.
The Department of Urology at The Mount Sinai Hospital is ranked No. 18 in the nation by U.S. News & World Report® for 2023-24.
The Milton and Carroll Petrie Department of Urology is part of the Mount Sinai Health System and has been a leader in clinical practice, research, and education since 1852, with the establishment of the Mount Sinai Hospital. Today, depth of knowledge, breadth of experience, and compassion for patients continue to characterize our highly respected team of board certified and fellowship trained physicians whom are also faculty of the Icahn School of Medicine at Mount Sinai. Our dedicated team of urologists specialize in treatment of urologic cancer, kidney stones, sexual dysfunction, and endourological conditions. Our surgeons and scientists have pioneered the adoption of novel diagnostic techniques and minimally invasive treatments for prostate, kidney, bladder, and renal cell cancers though our industry-leading international symposia.
As globally recognized experts, we provide in depth training on cutting-edge medical advances and are among the most renowned in the world performing robotic surgery making our robotics program among the most robust in the country. Our Kidney Stone Center was the first of its kind in New York, focusing on both treatment and prevention. Genomic testing and advanced imaging are routine for patients with prostate cancer in order to provide them with the most personalized and precise treatment protocols. Our specialized men’s, women’s, children’s, reconstructive and gender affirming programs ensure that we can meet the needs of every patient with exceptional quality of service.
The Department of Urology at The Mount Sinai Hospital is ranked No. 18 in the nation by U.S. News & World Report® for 2023-24.
Latest Content |view more
Harnessing Immunotherapy to Achieve Improved Outcomes for Patients With Prostate Cancer
Although there is considerable interest in using immunotherapy to combat and control prostate cancer, there has been little progress made in harnessing the potential of this approach.
An innovative effort by the Milton and Carroll Petrie Department of Urology and Ash Tewari, MBBS, MCh, FRCS (Hon.), Professor and System Chair, to improve early detection of prostate cancer among at-risk populations in New York City...
Transgender Surgery at the Department of Urology at Mount Sinai with Miroslav Djordjevic MD, PhD
Dr. Djordjevic of the Mount Sinai Department of Urology's transgender surgery program discusses a variety of feminizing genital surgery options for vaginoplasty and techniques for masculinizing genital surgery.
Transgender Surgery at the Department of Urology at Mount Sinai with Rajveer Purohit, MD, MPH
Dr. Purohit of the Mount Sinai Department of Urology's transgender surgery program shares feminizing genital surgery options for vaginoplasty, metoidioplasty and phalloplasty.
Case Study: Multidisciplinary Care for Renal Replacement Patient
A neonate with severe kidney injury and likely urinary blockage causing severe hydronephrosis received successful treatment at Mount Sinai for his rare birth defect.
Mount Sinai has developed a protocol that eliminates opioids from postoperative pain management with exceptional results.
Kidney Research Pipeline to Enhance Precision in Surgical Intervention Decisions
Advances in imaging, biomarkers, and genetic testing continue to benefit patients who present with prostate and bladder cancers.
Two Physician-Researchers Making Unique Contributions to Urology Innovation
Two physician-researchers in the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai have been recognized for making unique contributions to urology research...
Urology Training Program at Mount Sinai Offers Residents Unique Opportunities
The Urology Residency Program of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai provides residents the opportunity to train in all aspects of the medical and surgical evaluation and treatment ...
Mount Sinai’s Department of Urology continues to make strides in training a new generation in the necessary clinical, surgical, and decision-making skills to deliver outstanding care to patients in an area undergoing rapid change.
Advancing the Field of Gender Affirming Surgery Through Innovative Approaches
Mount Sinai has established itself as a leader in gender affirming surgery and reconstruction of genitalia, thanks in part to the pioneering work of Miroslav Djordjevic, MD, PhD, a leading authority on surgery for transgender individuals.
Prostate Cancer Program: Two Pioneering Studies
For more than a decade, Ash Tewari, MBBS, MCh, FRCS (Hon.), has been a leader in advancing the safety and precision of robot-assisted radical prostatectomies.
By continuing to perfect the miniaturization of percutaneous nephrolithotomy (PCNL), surgeons at the Mount Sinai Department of Urology are significantly improving outcomes for patients with larger kidney stones.
Better Diagnosis Holds the Key to Improved Outcomes for BPH Patients
As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
Organoids Enable Pathophysiology, Treatment Studies of Rare Renal Cell Carcinomas
For years, rare renal cell carcinomas (RCCs), such as papillary RCC, have been understudied because their incidences are too low to support clinical trials.
Message from the Chair: Milestones are meant to be celebrated and surpassed. For the year 2022, our milestones are a reflection of our collective efforts to save lives—through innovative patient care and groundbreaking research and scholastic activities.
Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates
Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle...
Mount Sinai Pediatric Stone Clinic Diagnoses, Treats, and Prevents Kidney Stones in Children
The Mount Sinai Pediatric Stone Clinic is a comprehensive, interdisciplinary program focused on the diagnosis, management, and prevention of kidney stones in children.
The COVID-19 pandemic forced us to find the strength we never knew we had. It has revealed our anti-fragile mindset in our mission to provide unparalleled, comprehensive, and innovative patient care.
Ash Tewari, MD presents insights into the role of genomics on prostate cancer
A Conversation With Deepak Chopra
Ash Tewari, MBBS, MCh, FRCS (Hon.) discusses wellness and well-being with Deepak Chopra, MD
Urology Training Program at Mount Sinai Prepares Residents for Success
Learn more about the Urology Residency Program of the Department of Urology at the Icahn School of Medicine at Mount Sinai
Ultra-Mini PCNL: A New Approach to Treating Kidney Stones
At Mount Sinai, Mantu Gupta, MD, a pioneer in PCNL procedures, is helping to popularize a new approach to treating kidney stones that is not only cost efficient but also safe and effective: ultra-mini PCNL
Offering Patients Innovative Options for Penile Enhancement
For years, Robert Valenzuela, MD, cautioned patients that they might experience shortening of their penis following a penile prosthesis implantation (PPI) for erectile dysfunction. Today, he advises them that they might have a longer one
Developing a Single Port Donor Nephrectomy Program to Provide Benefits for Patients
Michael Palese, MD continues to advance the standard of care for patients undergoing robotic multiport living donor nephrectomy (LDN)
Ketan Badani, MD believes a significant percentage of kidney and adrenal tumors can be done using a robot-assisted retroperitoneal approach
Mount Sinai and the NYC launch of a new Mobile Prostate Cancer Screening Unit aiding the Black Community.
Mount Sinai is developing a fully personalized therapeutic vaccine directed toward mutation-derived tumor antigens—in combination with CDX-301, a potent hematopoietic cytokine.
Aquablation is Proving to Be an Innovative and Successful Approach in BPH Procedures
Steven A. Kaplan, MD, using Aquablation® therapy, he is able to treat patients presenting with similar size prostates in approximately eight minutes
Mount Sinai Begins Offering High-Intensity Focused Ultrasound (HIFU) for Localized Prostate Tumors
Mount Sinai has begun offering patients high-intensity focused ultrasound (HIFU) for targeted ablation of localized prostate tumors
Dr. Tewari’s focus on precision medicine, scientific innovation, and offering patients more options exemplifies Mount Sinai’s leadership in translating insights from research to clinical practice
Precision Prostatectomy Approach Helps Preserve Erectile Function Among Patients
Mani Menon, MD discusses advances in robotic prostatectomy surgery
Robotic Approach to Testicular Cancer Treatment Potentially Safe, Effective, Reproducible
Mount Sinai Holds Prostate Cancer Research Stay at Home Gala to Showcase Research Priorities
The event highlighted the Department’s research in prostate cancer, beginning with the impact of the COVID-19 pandemic
Department Receives $4 Million Gift to Support Prostate Health
The donation from Lizzie and Jonathan Tisch will support prostate health and the Department of Urology and continues their generous history of philanthropic giving at Mount Sinai
Research Initiatives Include Two New Grants from the National Institutes of Health
The Department of Urology at the Icahn School of Medicine at Mount Sinai is building on its legacy of innovation in research and therapeutic treatments with two new National Institutes of Health grants focused on the mechanisms that drive ...
A review of data from around the world by Mount Sinai researchers confirms that men face a greater risk of infection and mortality from COVID-19 and that routine screening should be conducted for the disease among prostate cancer patients
Robotic Single Port Donor Nephrectomy
The team from Mount Sinai believes the new Single Port platform from Intuitive Surgical is uniquely suited for the LDN procedure
A review of COVID-19 literature could lead to effective simultaneous treatment of both diseases
Rezum Therapy for Patients with Large Prostate Glands
Michael A. Palese, MD, Professor of Urology at the Icahn School of Medicine at Mount Sinai and Director of Minimally Invasive Surgery, along with his team, evaluated the use of Rezum technology for prostates greater than 80 grams
A More Comprehensive, Patient-Centered Approach to Staghorn Calculi
Mount Sinai’s approach to care is focused on understanding the root causes of the disease by pioneering new treatments and developing customized postoperative regimens that reduce the risk of redevelopment, resulting in improved outcomes
Peter Wiklund, MD, PhD has become one of the first surgeons in the world to use a single-port robot to perform radical cystectomies with a urinary diversion
A Pioneering Approach to Gender Affirming Surgery from a World Leader in the Field
For years, the main challenge associated with gender affirming surgery has been the ability to provide patients with genitalia that is not only fully functional but also aesthetically acceptable.
Hood Technique Enables Early Return to Continence Following RARP
A novel surgical technique developed at Mount Sinai is showing considerable promise in facilitating early return of continence with low residual cancer rates among patients who have undergone robot-assisted radical prostatectomy
Mount Sinai’s Comprehensive Kidney Cancer Center brings together Mount Sinai’s extensive expertise in radiology, immunology, genomics, and clinical care to develop new diagnostic tools, pioneer more minimally invasive approaches to surgery, ...
The year 2020 was an unprecedented one for the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai and the Mount Sinai community as a whole. The COVID-19 pandemic put our normal operations on ...
Managing Pediatric Urologic Care During COVID-19
Fernando A. Ferrer, MD, FACS, FAAP, provides guidance for parents on managing their child’s pediatric urologic care
Keeping Patients Safe: A Message to Our Urology Patients
Mount Sinai is taking many precautions during the COVID-19 pandemic to keep patients safe who need urological care. Ashutosh Tewari, MBBS, MCh, discusses what patients can expect
Modified Percutaneous Nephrolithotomy (PCNL)
Mantu Gupta, MD, performs Modified Percutaneous Nephrolithotomy (PCNL) without modified instruments, a groundbreaking percutaneous kidney stone technique he developed that allows removal of large stones through a minimal incision and tract.
Prostatic Artery Embolization at Mount Sinai
Watch a PAE on a 74-year-old with a 20-year history of BPH.
An Overview of Minimally Invasive Prostate Artery Embolization at Mount Sinai
Hear directly from Aaron Fischman, MD, about how effectively PAE works for patients with urinary symptoms caused by BPH
Prostate Artery Embolization at Mount Sinai
Aaron Fischman, MD, performs embolization of both prostatic arteries as a minimally invasive, non-surgical treatment for BPH via the radial artery in the wrist
Transradial Balloon Occlusion Prostate Artery Embolization for BPH at Mount Sinai
Lower urinary tract symptoms had worsened in the months prior to the PAE
Hood Technique of Robotic Radical Prostatectomy
Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence without Compromising Surgical Margin Rates